Large clinical trials consistently demonstrate significant weight loss (often 1020% of body weight) when combined with lifestyle changes
StatNews reports that the tariffs would likely affect about $12 billion of the $274 billion in pharmaceuticals imported into the US annually, which would limit the impact of these tariffs on employer-sponsored health plans
The Ozempic Lawsuit focuses on claims that the diabetes and weight loss medication, Ozempic, has caused severe gastrointestinal issues, including gastroparesis (paralysis of the stomach), nausea, vomiting, and other serious side effects
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases
The correct intervention for dose-escalation nausea is not schedule modification
Expect sustained high-value therapy penetration the market will keep tilting toward premium molecules